#precisiononc hasil pencarian

Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

JCO_ASCO's tweet image. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

@eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

shilpaonc's tweet image. @eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca,  RR ~ 20% 
Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

.@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

JCO_ASCO's tweet image. Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

Mirdametinib continued to deliver durable tumor shrinkage in ReNeu, with deeper responses emerging as time on therapy increased for adults and children with NF1-PN. 📈 Details: hubs.li/Q03Wj7JQ0 #NF1 #PrecisionOnc


Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

UGrewalMD's tweet image. Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

JCO_ASCO's tweet image. Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

.@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

JCO_ASCO's tweet image. Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions. Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc

ThejusJay's tweet image. Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions.
Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc

Mirdametinib continued to deliver durable tumor shrinkage in ReNeu, with deeper responses emerging as time on therapy increased for adults and children with NF1-PN. 📈 Details: hubs.li/Q03Wj7JQ0 #NF1 #PrecisionOnc


We are big fans of early genomic profiling 🧬 in #PDAC and other malignancies with actionable mutations in early stage and localized disease @OHSUKnight #GiveCancerHell #precisiononc

Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adenocarcinoma. Read the full article. brnw.ch/21wXYSY #pamcsm



💡 One event. All the breakthroughs. The Best of Precision & Immuno-Oncology returns October 3. Get expert-led updates in immuno and precision oncology from the comfort of your screen. Register today! ow.ly/ehWI50WKwcJ #BoPIO #PrecisionOnc #ImmunoOnc #MedOnc

OncEd's tweet image. 💡 One event. All the breakthroughs. The Best of Precision & Immuno-Oncology returns October 3. Get expert-led updates in immuno and precision oncology from the comfort of your screen. 

Register today! ow.ly/ehWI50WKwcJ

#BoPIO #PrecisionOnc #ImmunoOnc #MedOnc

Congrats for being a beacon of hope and science for us all #precisiononc


@eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

shilpaonc's tweet image. @eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca,  RR ~ 20% 
Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions. Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc

ThejusJay's tweet image. Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions.
Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc

“Reimagining clinical trials in #precisiononc by the Top Leader in the Field @Dr_R_Kurzrock , Mellowes Center-Cancer Center Associate Director. Delivered to the wonderful @UIowaCancer Center @MCWCancerCenter @MedicalCollege @MCWPediatrics @RareCancerRF @RareDiseases @UDNconnect

Thank you for the honor to speak to University of Iowa. Absolutely superb questions.



Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

UGrewalMD's tweet image. Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

We're thrilled to have world-renowned clinicians Dr. Tak Mak and @DrJasPlummer delivering keynote presentations at our upcoming Best of Precision Oncology 2023 Conference. Register today for this in-person event: oncologyeducation.com/events/bopo202… #OncEd #PrecisionOnc @navstruck @hmcarthur

OncEd's tweet image. We're thrilled to have world-renowned clinicians Dr. Tak Mak and @DrJasPlummer delivering keynote presentations at our upcoming Best of Precision Oncology 2023 Conference.  Register today for this in-person event: oncologyeducation.com/events/bopo202…
#OncEd #PrecisionOnc @navstruck @hmcarthur

Don’t miss Best of Precision Oncology 2023 where world-renowned oncologist Dr. Tak Mak will deliver a can’t-miss keynote, Novel Promising Targets Beyond Checkpoint Blockade. Register today: ow.ly/hm9M50PE6Fa #PrecisionOnc #Cancer #CancerCare @hmcarthur @navstruck

OncEd's tweet image. Don’t miss Best of Precision Oncology 2023 where world-renowned oncologist Dr. Tak Mak will deliver a can’t-miss keynote, Novel Promising Targets Beyond Checkpoint Blockade. Register today: ow.ly/hm9M50PE6Fa

#PrecisionOnc #Cancer #CancerCare @hmcarthur @navstruck

Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer #rarecancer #VHA #precisiononc

JeremyKratz's tweet image. Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer  #rarecancer #VHA #precisiononc

Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO

JCO_ASCO's tweet image. Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO

An overview of recent efforts and feasibility of implementing precision oncology efforts across diverse geographical settings fal.cn/3fJ4d #precisiononc #JCOPO


Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

JCO_ASCO's tweet image. Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

Barriers to prescribing targeted therapies for patients with NSCLC and highly actionable gene variants in the VA precision oncology program fal.cn/3eycT #lcsm #precisiononc #JCOOP

JCO_ASCO's tweet image. Barriers to prescribing targeted therapies for patients with NSCLC and highly actionable gene variants in the VA precision oncology program fal.cn/3eycT #lcsm #precisiononc #JCOOP

Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

JCO_ASCO's tweet image. Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

Editorial: Precision medicine in DLBCL -- are we there yet? fal.cn/3e8Bb #precisiononc #lymsm


Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

JCO_ASCO's tweet image. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

JCO_ASCO's tweet image. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

JCO_ASCO's tweet image. Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

.@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

JCO_ASCO's tweet image. Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

@eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

shilpaonc's tweet image. @eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca,  RR ~ 20% 
Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

JCO_ASCO's tweet image. Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

UGrewalMD's tweet image. Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

.@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO

JCO_ASCO's tweet image. Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO

We're thrilled to have world-renowned clinicians Dr. Tak Mak and @DrJasPlummer delivering keynote presentations at our upcoming Best of Precision Oncology 2023 Conference. Register today for this in-person event: oncologyeducation.com/events/bopo202… #OncEd #PrecisionOnc @navstruck @hmcarthur

OncEd's tweet image. We're thrilled to have world-renowned clinicians Dr. Tak Mak and @DrJasPlummer delivering keynote presentations at our upcoming Best of Precision Oncology 2023 Conference.  Register today for this in-person event: oncologyeducation.com/events/bopo202…
#OncEd #PrecisionOnc @navstruck @hmcarthur

Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer #rarecancer #VHA #precisiononc

JeremyKratz's tweet image. Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer  #rarecancer #VHA #precisiononc

Loading...

Something went wrong.


Something went wrong.


United States Trends